Bioqual (OTCMKTS:BIOQ) Stock Falls 7.2% – Time to Sell?

Bioqual Inc. (OTCMKTS:BIOQ) shares traded down 7.2% during trading on Wednesday. The company traded as low as $30.64 and last traded at $30.64. 900 shares traded hands during mid-day trading, an increase of 33,862% from the average daily volume of 3 shares. The stock had previously closed at $33.00.

Bioqual Price Performance

The firm has a fifty day moving average price of $32.83 and a two-hundred day moving average price of $33.65. The stock has a market capitalization of $27.39 million, a P/E ratio of -7.03 and a beta of -0.10.

Bioqual (OTCMKTS:BIOQ) last announced its quarterly earnings results on Thursday, October 22nd. The company reported ($0.56) earnings per share (EPS) for the quarter. Bioqual had a negative net margin of 9.75% and a negative return on equity of 11.20%. The company had revenue of $10.15 million for the quarter.

About Bioqual

Bioqual, Inc is a biomedical research and contract research organization based in Rockville, Maryland. The company provides preclinical research services to pharmaceutical and biotechnology companies, government agencies, and other organizations involved in the development of medical products.

Its work focuses primarily on infectious diseases, vaccines, therapeutics, and diagnostics. Bioqual conducts laboratory and animal-model studies designed to evaluate the safety, efficacy, immunology, virology, and pharmacology of potential treatments and preventive products.